Overview
CD58, also known as lymphocyte function-associated antigen 3 (LFA-3), is crucial for immune recognition, facilitating interactions between tumor cells and cytotoxic T cells and natural killer (NK) cells.
Experimental Evidence
In DLBCL, mutations prevent the expression of CD58 on the cell surface, impairing the ability of T and NK cells to recognize and attack the tumor cells. This is often accompanied by mutations in the β2-Microglobulin gene, which further aids in immune evasion.1
Relevance tier by entity
Cannot include /table1_CD58.md - does not exist yet
Mutation incidence in large patient cohorts (GAMBL reanalysis)
DLBCL
Cannot include /DLBCL_CD58.md - does not exist yet
Mutation pattern and selective pressure estimates
Cannot include /dnds_CD58.md - does not exist yet
Cannot include /browser_CD58.md - does not exist yet
Expression
Cannot include /mermaid_CD58.md - does not exist yet


